Vimarsana
Biggest News Aggregation in the World

Page 17 - Dirk Neum News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Dirk Neum. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Dirk Neum Today - Breaking & Trending Today

Biotest AG: Biotest receives approval for phase III clinical trial in pregnant women for prevention - Vimarsana News

Biotest AG: Biotest receives approval for phase III clinical trial in pregnant women for prevention

DGAP-News: Biotest AG / Key word(s): Study26.08.2021 / 07:00 The issuer is solely responsible for the content of this announcement.PRESS RELEASEBiotest receives approval for phase III clinical trial in pregnant women for prevention of CMV infection of the unborn baby Infection of the foetus with Cytomegalovirus (CMV...

Biotest AG: Biotest AG opens 11th plasma collection centre in Hungary - Vimarsana News

Biotest AG: Biotest AG opens 11th plasma collection centre in Hungary

- 25 plasma collection centres in Europe to ensure long-term plasma supply Dreieich, 20 July 2021. Biotest received an operating permit for its 11 th plasma collection centre in Hungary from the country's national public health authority OTH. The centre is located in a shopping centre in the north-western Hungarian university town of Sopron and is one of the most modern in Europe. The centre, equipped with 20 donor beds, has created 24 new jobs in Sopron. Thus, the company is further expanding its plasma collection capacity and is safeguarding the plasma supply to future growth. The first pla...

Source: dgap.de
Biotest AG: Biotest successfully completes recruitment for its clinical trial with trimodulin in sev - Vimarsana News

Biotest AG: Biotest successfully completes recruitment for its clinical trial with trimodulin in sev

DGAP-News: Biotest AG / Key word(s): Study02.06.2021 / 07:00 The issuer is solely responsible for the content of this announcement.PRESS RELEASEBiotest successfully completes recruitment for its clinical trial with trimodulin in severe COVID-19 patients - Trimodulin as potential life-saving treatment for severe COVI...

Biotest AG: Biotest increases sales by more than 22 % in the first quarter of 2021 to 120 million E - Vimarsana News

Biotest AG: Biotest increases sales by more than 22 % in the first quarter of 2021 to 120 million E

- EBIT burdened by product mix, plasma costs and increased hygiene expenses - Forecast for 2021 confirmed May, 2021. The Biotest Group recorded revenue of € 120.0 million in the first quarter of 2021. This represents an increase of 22.8 % compared to revenue of € 97.7 million in the same period of the previous year. In terms of revenue, Biotest closed a strong first quarter, which was characterised by a worldwide increase in demand for immunoglobulins while the pandemic situation remained difficult. In particular, sales of Intratect (R), Biotest's standard immunoglobulin, were significant...

Biotest AG: Biotest AG opens 10th plasma collection centre in Hungary - Vimarsana News

Biotest AG: Biotest AG opens 10th plasma collection centre in Hungary

06.05.2021 Biotest AG: Biotest AG opens 10th plasma collection centre in Hungary | Biotest AG | News | Nachricht | Mitteilung

Source: dgap.de